At Biotech Week Boston, we sat down with Tyler Merkeley, Health Scientist, Head of Special Projects & Portfolio Management at BARDA for an exclusive interview. He was also a panelist on the discussion on “How to Overcome the Funding Gap for Biotech Start-ups and Emerging Companies“.
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services office responsible for procurement and development of countermeasures principally against bioterrorism, but also including chemical, nuclear and radiological threats. Naturally, they are responsible for a national preparedness for pandemic and emerging threats.
In this interview, Tyler explores the relationship between the government and BARDA with start-ups. Specifically discussing;
- What elements of overcoming the funding gap for biotech start-ups are especially relevant to BARDA’s work?
- What is the impact to the industry when good start-ups with great technologies fail in early stages from lack of funding?
- What advice do you have for start-up companies who are looking to innovate this space?